NCBiotech News

When COVID-19 upended his college aspirations, Carl May deferred his freshman year to battle the bug in his family business, Andersen Sterilizers, processing millions of swabs at the company's Morrisville contract sterilization facility and learning much in the process.

North Carolina military service members are taking the next step in their careers thanks to a program linking their interpersonal and leadership skills with targeted technical training. 

Jellatech is a Raleigh startup that is developing a process producing the same collagen that comes from animals --without using any animals.

British dermatology CDMO MedPharm is actively hiring as it spools up manufacturing operations at its new 15,000-square-foot Morrisville site.

A Raleigh biotechnology startup is putting an initial $26 million investment into the establishment of a teamwork approach to enhance efficiencies for cell- and gene-based cancer therapy developers.

Heat Biologics says it is doubling the size of its R&D facilities in Morrisville to some 15,000 square feet, to better support its drug development programs.

NCBiotech board member Michelle Berrey, M.D., has been appointed the president of research & development and chief medical officer at New-York-based biopharmaceutical innovator Intercept Pharmaceuticals.

Raleigh-based Veranex and global investment firm Summit Partners said they are joining forces to create a soup-to-nuts service provider for the medical technology industry.

The National Institutes of Health (NIH) awarded a $1.74 million research grant to study diabetic kidney disease to Elimelda Moige Ongeri, Ph.D., a professor and associate dean for research and innovation at North Carolina Agricultural and Technical State University.

If you're interested in learning about a career in North Carolina’s growing biomanufacturing sector, mark your calendar for Thursday, June 24, when Merck and BioNetwork will host a virtual career fair.

RTP's Biomason will develop biocement floor tiles with one of Europe’s largest fashion houses, H&M Group, for use in its retail stores.

The fast evolution of the COVID-19 outbreak into this global pandemic sparked an equally fast response from all quarters of North Carolina’s diverse life sciences community.

Verona Pharma, with U.S. headquarters in Raleigh, has clinched a $219 million deal to market its “first-in-class” drug, ensifentrine, targeting chronic obstructive pulmonary disease (COPD), in China.

With grant support from NCBiotech, engineers at Duke University have demonstrated a prototype X-ray scanning machine that reveals not just the shape of an object but its molecular composition.

Jonathan Maynard has traveled a long career path that will one day allow him to return to South Korea. And, it all started with JCC’s BioWork certificate program.